Trial Profile
Beta cell imaging in type 1 diabetes with stable near-normal and unstable glucose control using PET
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Diagnostic use; Pharmacodynamics
- Acronyms GLP-reg
- 27 Jun 2021 This trial has been discontinued in Netherlands, as per European Clinical Trials Database record.
- 03 Aug 2017 New trial record